Smith & Nephew (SNN) FCF Margin Growth (3y) (2012 - 2024)
Smith & Nephew (SNN) FCF Margin Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 38.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 30.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -310.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 96.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -2,196.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,679.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -20.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -472.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 417.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -65.00 |
| Dec 31, 2022 | -976.00 |
| Dec 31, 2021 | -749.00 |
| Dec 31, 2020 | -686.00 |
| Dec 31, 2019 | -42.00 |
| Dec 31, 2018 | -154.00 |
| Dec 31, 2017 | -80.00 |
| Dec 31, 2016 | -1,116.00 |
| Dec 31, 2015 | 1,037.00 |
| Dec 31, 2014 | 1,406.00 |
| Sep 30, 2014 | 836.00 |
| Mar 31, 2014 | -649,224.81 Bn |
| Dec 31, 2013 | -743.72 Mn |
| Mar 31, 2013 | -1.00 Bn |
| Dec 31, 2012 | 1,024.00 |
| Jun 30, 2012 | 1.38 Bn |
| Mar 31, 2012 | -1,097,560.98 Bn |